good coverage today

http://www.skinandallergynews.com/news/medical-dermatology/single-article/afamelanotide-implants-effective-for-erythropoietic-protoporphyria/9d113eb38f.html

The industry new source is a little dated with their article, but it's good coverage.

I like Dr. Minder's comments, but on the downside, while I knew the injection caused mild nausea for some, I didn't know that the implant also causes some short-term nausea in some patients - 33% in the trial - that's quite high to me.

I'm guessing the nausea is very short-term and would have little impact on one's decision to get future implants.

Doesn't appear to me Clinuvel will start the vitiligo trial in October as it was previously projected when they first mentioned it 6 weeks or so ago. Just a few weeks left in Oct., and unless they simply haven't announced it yet, the FDA apparently still has not given the green light. If they have, the market would want to hear that.